Clinical trial
Endovascular Stroke Treatment And Reteplase Protocol
NCT05900674 is registered in ClinicalTrials.gov with Zeenat Qureshi Stroke Institute as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Endovascular Stroke Treatment And Reteplase Protocol
- Lead sponsor
- Zeenat Qureshi Stroke Institute
- Phase
- Phase 2
- Overall status
- Withdrawn
- Start date
- July 31, 2023
- Completion date
- July 31, 2024
- Enrollment
- 0 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.